Darifenacin Tablet, Extended Release
Product Images NDC 46708-223
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Darifenacin (NDC 46708-223). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Darifenacin Figure1)
Figure 2a (Darifenacin Figurea2)
Figure 2b (Darifenacin Figureb2)
Figure 2c (Darifenacin Figurec2)
30's Bottle Pack (Darifenacin 75mg)
30's Bottle Pack (Darifenacin 15mg)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.